I just want to say I feel Dr. Bray is an exceptional addition to an already impressive collective effort to move ahead with the medical , and economic benefits realized by empowering new understandings about phytocannabinoids.
Dr. Bray held various positions of responsibility at GlaxoSmithKline.
Director, Clinical Development HIV, GlaxoSmithKline, UK,
Senior Medical Strategy Head, International Medical Affairs, Glaxo Wellcome Inc, USA:
Principal Clinical Research Scientist, Antivirals, Glaxo Wellcome, UK and USA:
Senior Clinical Research Scientist, HIV, The Wellcome Foundation, UK
Dr. Bray’s extensive experience in the field of HIV drug development will compliment Cannabis Sciences’ prestigious Scientific Advisory Board as the company embarks on the research and development of a phytocannabinoid based HIV TAT inhibitor. Dr. Bray has significant expertise in clinical development and market positioning for novel drugs.
PS And your comment...
It's like playing chess..Dr Bob is the King,Dorothy Bray is the Queen ...Dr. Moe Afaneh one of the knights along with Dr. Roscoe M. Moore Jr., and I guess we are the pawns?
I say....at least....we are in the game which is where I want to be....many more agree with us on that score as time grows...Waitng for What?.... CBIS is not waiting...
Best Wishes
